Four Cases of Facial Discoid Lupus Erythematosus Successfully Treated with Topical Pimecrolimus or Tacrolimus.
- Author:
Ye Won HAN
1
;
Hyung Ok KIM
;
Sung Hwan PARK
;
Young Min PARK
Author Information
- Publication Type:Case Report
- Keywords: Discoid lupus erythematosus; Pimecrolimus; Tacrolimus
- MeSH: Lupus Erythematosus, Discoid; Steroids; Tacrolimus
- From:Annals of Dermatology 2010;22(3):307-311
- CountryRepublic of Korea
- Language:English
- Abstract: Discoid lupus erythematosus (DLE), which is a cutaneous form of lupus erythematosus (LE), is generally refractory to a wide range of topical or systemic therapies. Although the main treatment option for DLE is topical steroids, it is often ineffective or likely to produce long-term side effects. New drugs, including tacrolimus and pimecrolimus, have been developed to overcome the adverse effects of steroids and treat the lesions of DLE for a prolonged period. We herein report 4 cases of facial DLE successfully treated with therapeutic adjuvants, topical tacrolimus or pimecrolimus.
